JESÚS FERNANDO SAN MIGUEL IZQUIERDO-rekin lankidetzan egindako argitalpenak (5)

2016

  1. Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development

    Journal of Hematology and Oncology, Vol. 9, Núm. 1

2012

  1. Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effects

    PLoS ONE, Vol. 7, Núm. 4

2010

  1. Both CD133+ cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells

    Cell Transplantation, Vol. 19, Núm. 1, pp. 103-112

  2. Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: Comparison with bone marrow mesenchymal stromal cells from the same subjects

    Spine, Vol. 35, Núm. 26, pp. 2259-2265

2001

  1. Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making process

    Transfusion, Vol. 41, Núm. 10, pp. 1212-1216